Lopinavir/Ritonavir (LPV/r) Oral Solution - Effective Protease Inhibitor for HIV-1 Management

Short description

Lopinavir/Ritonavir (LPV/r) Oral Solution 80+20mg/ml | Potent HIV-1 Protease Inhibitor

  • Type: Dual-Active Pharmaceutical Ingredient formulation – Lopinavir 80mg/ml and Ritonavir 20mg/ml.
  • Formulation: User-friendly oral solution is meticulously engineered for superior HIV-1 management.
  • Indication: Purposefully designed for the treatment of HIV-1 infection in adults and children above 2 years, in conjunction with a minimum of two other antiretroviral drugs.
  • Storage: It is advised to store the product between 2u00b0C-8u00b0C prior to dispensing and under 25u00b0C post-dispensing, effective for up to six weeks.
  • Dispensing: Comes in the original packaging which sustains the product’s integrity and discourages repacking.
  • Volume: The package includes 5 60ml-bottles.
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Delivery options
  • 7 Days Return Back Policy
  • 2 Days Cancellation Policy
  • Ship Only

Lopinavir/Ritonavir (LPV/r) Oral Solution 80+20mg/ml is a pioneering therapeutic solution specifically designed to combat HIV-1 in adults and children above the age of 2. This solution belongs to the distinguished class of Protease Inhibitors (PI), making it an effective defense against HIV-1. The package contains 5 bottles, each with a volume of 60ml, and each milliliter is imbued with a strong concentration of 80mg Lopinavir and 20mg Ritonavir.

Lopinavir/Ritonavir is recognized for its boosted protease inhibitor function, a feature that puts it at the forefront of HIV management. The protease inhibitors operate by restraining the viral protease, a crucial enzyme needed by HIV-1 for replication. The drug's oral administration route promotes easy, non-invasive application and widespread inhibition of HIV-1 propagation.

  • Product Features:
  • Therapeutic Class: Protease Inhibitors (PI)
  • Contains Lopinavir and Ritonavir in a potent 80+20mg/ml concentration
  • Consumer-friendly oral administration
  • Prequalified by the World Health Organization for managing HIV-1 in adults and children aged 2+ years
  • Intended for use in combination with at least two other antiretroviral drugs
  • Shelf-life of 2 years for guaranteed long-term use
  • Storage requirements: 2°C - 8°C prior to dispensing, below 25°C for up to six weeks after dispensing
  • Must be kept in original packaging; repacking not recommended

The Lopinavir/Ritonavir (LPV/r) Oral Solution 80+20mg/ml has demonstrated considerable effectiveness against HIV-1 as evident by its prequalification from the World Health Organization (WHO). This potent and reliable solution embodies our commitment to providing the highest level of patient care.

All categories